This topic contains a solution. Click here to go to the answer

Author Question: Australopithecus boisei lived between __________. a. 2.3 and 1.2 mya b. 3.1 and 2.5 mya c. 3.5 ... (Read 87 times)

Pea0909berry

  • Hero Member
  • *****
  • Posts: 573
Australopithecus boisei lived between __________.
 
  a. 2.3 and 1.2 mya
  b. 3.1 and 2.5 mya
  c. 3.5 and 2.2 mya
  d. 2.3 and 1.5 mya

Question 2

Australopithecus robustus represents robust australopithecines in __________.
 
  a. Ethiopia
  b. east Africa
  c. southern Africa
  d. Kenya



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mammy1697

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

Answer a

Answer to Question 2

Answer c




Pea0909berry

  • Member
  • Posts: 573
Reply 2 on: Jul 10, 2018
:D TYSM


EAN94

  • Member
  • Posts: 307
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library